thymidine has been researched along with leflunomide in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chong, AS; Finnegan, A; Foster, P; Gebel, H; Jiang, XL; Petraitis, EE; Sankary, HN; Williams, JW | 1 |
| Cao, W; Morris, RE; Shorthouse, R; Silva, HT | 1 |
| Morris, RE; Shorthouse, R; Silva, HT | 1 |
3 other study(ies) available for thymidine and leflunomide
| Article | Year |
|---|---|
Leflunomide, a novel immunomodulatory agent: in vitro analyses of the mechanism of immunosuppression.
Topics: Cells, Cultured; Cyclosporine; Dose-Response Relationship, Drug; Drug Interactions; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Isoxazoles; Leflunomide; Lymphocyte Activation; Polyenes; Sirolimus; T-Lymphocytes; Thymidine; Tritium | 1993 |
Mechanism of action of leflunomide: in vivo uridine administration reverses its inhibition of lymphocyte proliferation.
Topics: Animals; Dihydroorotate Dehydrogenase; Immunosuppressive Agents; Isoxazoles; Leflunomide; Lymphocyte Activation; Male; Oxidoreductases; Oxidoreductases Acting on CH-CH Group Donors; Rats; Rats, Inbred Lew; Thymidine; Uridine | 1996 |
Single- and multiple-dose pharmacokinetics and pharmacodynamics of leflunomide's active metabolite A77 1726 in normal Lewis rats.
Topics: Administration, Oral; Aniline Compounds; Animals; Crotonates; DNA; Dose-Response Relationship, Drug; Drug Administration Schedule; Hydroxybutyrates; Immunosuppressive Agents; Isoxazoles; Leflunomide; Lymphocyte Activation; Male; Metabolic Clearance Rate; Nitriles; Rats; Rats, Inbred Lew; Thymidine; Time Factors; Toluidines | 1996 |